Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
INFINITY PHARMACEUTICALS, INC.Listing unverified | Sell | $219.2M | SEC | ||
INFINITY PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
INFINITY PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
INFINITY PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
INFINITY PHARMACEUTICALS, INC.Listing unverified | Buy | $78.5M | conv 58First in 12mo | SEC | |
INFINITY PHARMACEUTICALS, INC.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
INFINITY PHARMACEUTICALS, INC.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
INFINITY PHARMACEUTICALS, INC.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
INFINITY PHARMACEUTICALS, INC.Listing unverified | Buy | $15M | conv 60ClusterFirst in 12mo | SEC |